Future subcutaneous Herceptin studies could lead to patient-administration
18 October 2011
Sukaina Virji
Please Login to read the full article.
18 October 2011
Sukaina Virji
Please Login to read the full article.
RELATED CONTENT
NEWS
- Roche's T-DM1 (Herceptin-plus) shows early benefit in first-line metastatic breast cancer
- Iron chelator, prostate cancer conundrum on deck for ODAC
- NICE no for Tyverb and Herceptin in breast cancer, Roche considers appeal
- EMILIA supports Roche's T-DM1 filing but MARIANNE will be key to market performance
ANALYSIS
Other Informa Analysis
FEATURES
- Interview: Adimab's Gerngross seeks two sweethearts
- Chinese producers may be losing price edge to India, says Granules MD
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
